内皮与平滑肌细胞经FoxM1信号交互介导血管重塑与肺动脉高压
本研究探讨内皮细胞与平滑肌细胞交互及FoxM1信号在肺动脉高压血管重塑中的作用。采用多种基因敲除小鼠、PAH患者肺组织及PH大鼠模型,发现内皮来源因子诱导平滑肌FoxM1表达促进增殖和PH,药物抑制FoxM1可减轻严重PH。
要点
- 平滑肌细胞特异性Foxm1缺失可保护小鼠免受缺氧或Sugen/hypoxia诱导的PH。
- 内皮来源PDGF-B、CXCL12、ET-1和MIF诱导平滑肌FoxM1表达及增殖。
- FoxM1抑制剂thiostrepton在Sugen/hypoxia和野百合碱大鼠中抑制严重PH。
核心结论
- 功能失调内皮细胞来源的多种因子诱导平滑肌细胞FoxM1表达,激活FoxM1依赖的平滑肌增殖,参与肺血管重塑和PH。
- 靶向FoxM1信号是治疗特发性PAH的新策略。
研究设计与样本
- 使用平滑肌特异性Foxm1或Cxcr4敲除小鼠、内皮特异性Foxm1或Egln1敲除小鼠及内皮特异性Egln1/Cxcl12双敲除小鼠。
- 使用PAH患者肺组织和细胞验证临床相关性。
- 在Sugen 5416/缺氧和野百合碱攻击的大鼠中使用FoxM1抑制剂thiostrepton。
主要发现
- FoxM1表达在特发性PAH患者肺组织和肺动脉平滑肌细胞及四种PH啮齿动物模型中显著上调。
- 平滑肌(而非内皮)特异性Foxm1缺失小鼠免受缺氧或Sugen 5416/缺氧诱导的PH。
- 内皮来源PDGF-B、CXCL12、ET-1和MIF诱导平滑肌FoxM1上调并介导平滑肌增殖。
- 内皮Cxcl12缺失或平滑肌Cxcr4缺失抑制FoxM1表达、平滑肌增殖和PH。
- 药理学抑制FoxM1抑制Sugen 5416/缺氧和野百合碱大鼠的严重PH。
临床怎么用
- FoxM1信号通路可作为特发性PAH的潜在治疗靶点。
- 需进一步临床研究验证FoxM1抑制剂在PAH患者中的疗效与安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Angioproliferative vasculopathy is a hallmark of pulmonary arterial hypertension (PAH). However, little is known about how endothelial cell (EC) and smooth muscle cell (SMC) crosstalk regulates the angioproliferative vascular remodeling. OBJECTIVES: To investigate the role of EC and SMC interaction and underlying signaling pathways in pulmonary hypertension (PH) development. METHODS: SMC-specific Foxm1 (forkhead box M1) or Cxcr4 knockout mice, EC-specific Foxm1 or Egln1 knockout mice, and EC-specific Egln1/Cxcl12 double knockout mice were used to assess the role of FoxM1 on SMC proliferation and PH. Lung tissues and cells from patients with PAH were used to validate clinical relevance. FoxM1 inhibitor thiostrepton was used in Sugen 5416/hypoxia- and monocrotaline-challenged rats. MEASUREMENTS AND MAIN RESULTS: FoxM1 expression was markedly upregulated in lungs and pulmonary arterial SMCs of patients with idiopathic PAH and four discrete PH rodent models. Mice with SMC- (but not EC-) specific deletion of Foxm1 were protected from hypoxia- or Sugen 5416/hypoxia-induced PH. The upregulation of FoxM1 in SMCs induced by multiple EC-derived factors (PDGF-B, CXCL12, ET-1, and MIF) mediated SMC proliferation. Genetic deletion of endothelial Cxcl12 in Egln1Tie2Cre mice or loss of its cognate receptor Cxcr4 in SMCs in hypoxia-treated mice inhibited FoxM1 expression, SMC proliferation, and PH. Accordingly, pharmacologic inhibition of FoxM1 inhibited severe PH in both Sugen 5416/hypoxia and monocrotaline-challenged rats. CONCLUSIONS: Multiple factors derived from dysfunctional ECs induced FoxM1 expression in SMCs and activated FoxM1-dependent SMC proliferation, which contributes to pulmonary vascular remodeling and PH. Thus, targeting FoxM1 signaling represents a novel strategy for treatment of idiopathic PAH.
引用
- Dai Z, Zhu MM, Peng Y, et al. Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension. Am J Respir Crit Care Med. 2018. PMID: 29664678. doi:10.1164/rccm.201709-1835OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。